Ask AI

The Next Chapter in CSU: Expert Dialogues in Diagnosis and Leveraging New and Emerging Therapies

Deepen your understanding of the pathophysiology of chronic spontaneous urticaria (CSU), what factors contribute to disease burden, and the latest data on new and emerging CSU therapies, through an expert-written ClinicalThought, downloadable slides, and an on-demand webcast.

Share

Program Content

Events

Activities

Novel Targeted CSU Therapies
The Next Chapter in CSU: How Novel Targeted Therapies Are Transforming Practice 
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation